Lattice Biologics Ltd.
LBLTF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | |
|---|---|---|---|---|---|
| Net Income | -951.60K | -1.25M | -1.68M | -1.48M | -1.91M |
| Total Depreciation and Amortization | 179.70K | 231.50K | 369.60K | 381.00K | 253.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -795.30K | -786.10K | -12.80K | -35.20K | 906.60K |
| Change in Net Operating Assets | 1.44M | 1.57M | 1.68M | 1.67M | 749.10K |
| Cash from Operations | -132.10K | -227.50K | 351.20K | 536.10K | -2.50K |
| Capital Expenditure | -567.80K | -567.80K | -576.60K | -592.10K | -22.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -567.80K | -567.80K | -576.60K | -592.10K | -22.80K |
| Total Debt Issued | 161.50K | 321.50K | 515.50K | 321.50K | 160.00K |
| Total Debt Repaid | -108.50K | -165.70K | -284.50K | -224.00K | -121.10K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 684.90K | -- | -- | -- |
| Cash from Financing | 52.90K | 840.60K | 230.90K | 97.50K | 38.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 658.50K | 3.30K | -- | -- | -- |
| Net Change in Cash | 11.80K | 48.80K | 5.60K | 41.50K | 13.60K |